Device
Individualized connectome-guided accelerated iTBS
Individualized connectome-guided accelerated iTBS is a medical device with 2 clinical trials. Currently 1 active trials ongoing.
Total Trials
2
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
1(50%)
Phase Distribution
Ph not_applicable
1
50%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
2
all time
Status Distribution
Active(1)
Detailed Status
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
1
Active
1
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
recruiting1100%
Recent Activity
1 active trials
Showing 2 of 2
not_yet_recruitingnot_applicable
Mapping the Neural Circuits of Depression and Anxiety Using Personalized, Accelerated TMS and Deep Phenotyping
NCT07766291
recruitingnot_applicable
A Novel Individualized Connectome-guided Approach for Precision Intermittent Theta Burst Stimulation for Depression
NCT06385223
Clinical Trials (2)
Showing 2 of 2 trials
NCT07766291Not Applicable
Mapping the Neural Circuits of Depression and Anxiety Using Personalized, Accelerated TMS and Deep Phenotyping
NCT06385223Not Applicable
A Novel Individualized Connectome-guided Approach for Precision Intermittent Theta Burst Stimulation for Depression
All 2 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 2